Regulatory T (Treg) cells, which represent 5% to 10% of peripheral T cells, regulate the activities of T-cell subsets by performing immunosuppressive functions and thus preventing the development of autoimmune responses. The majority of Treg cells are CD4+, CD25+, and FOXP3+. Recently, it has been demonstrated that the tumor cells in adult T-cell leukemia lymphomas can function as Treg, raising the question of whether any variant of primary cutaneous T-cell lymphoma may also express a regulatory phenotype. We describe an extraordinary case of primary cutaneous T-cell lymphoma clinically characterized by protean cutaneous manifestations and histologically showing a pattern consistent with epidermotropic pleomorphic medium-/large-cell primary cutaneous T-cell lymphoma. The majority of neoplastic cells were CD4+ CD25+ T cells and strongly expressed FOXP3. With this background, the current case, characterized by an aggressive course requiring polychemotherapy, may support the existence of lymphoproliferative malignancies of Treg cells.

Marzano, A., Vezzoli, P., Fanoni, D., Venegoni, L., Berti, E. (2009). Primary cutaneous T-cell lymphoma expressing FOXP3: A case report supporting the existence of malignancies of regulatory T cells. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 61(2), 348-355 [10.1016/j.jaad.2008.11.894].

Primary cutaneous T-cell lymphoma expressing FOXP3: A case report supporting the existence of malignancies of regulatory T cells

BERTI, EMILIO
2009

Abstract

Regulatory T (Treg) cells, which represent 5% to 10% of peripheral T cells, regulate the activities of T-cell subsets by performing immunosuppressive functions and thus preventing the development of autoimmune responses. The majority of Treg cells are CD4+, CD25+, and FOXP3+. Recently, it has been demonstrated that the tumor cells in adult T-cell leukemia lymphomas can function as Treg, raising the question of whether any variant of primary cutaneous T-cell lymphoma may also express a regulatory phenotype. We describe an extraordinary case of primary cutaneous T-cell lymphoma clinically characterized by protean cutaneous manifestations and histologically showing a pattern consistent with epidermotropic pleomorphic medium-/large-cell primary cutaneous T-cell lymphoma. The majority of neoplastic cells were CD4+ CD25+ T cells and strongly expressed FOXP3. With this background, the current case, characterized by an aggressive course requiring polychemotherapy, may support the existence of lymphoproliferative malignancies of Treg cells.
Articolo in rivista - Articolo scientifico
Risk Assessment; Treatment Outcome; Male; Gene Expression Regulation, Neoplastic; Lymphocyte Activation; Immunohistochemistry; Forkhead Transcription Factors; Lymphoma, T-Cell, Cutaneous; Biopsy, Needle; Humans; Follow-Up Studies; Skin Neoplasms; Biological Markers; Antineoplastic Combined Chemotherapy Protocols; Aged; CD4-Positive T-Lymphocytes; T-Lymphocytes, Regulatory
English
2009
61
2
348
355
none
Marzano, A., Vezzoli, P., Fanoni, D., Venegoni, L., Berti, E. (2009). Primary cutaneous T-cell lymphoma expressing FOXP3: A case report supporting the existence of malignancies of regulatory T cells. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 61(2), 348-355 [10.1016/j.jaad.2008.11.894].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/15093
Citazioni
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 10
Social impact